Cargando…
Infection-Induced SARS-CoV-2 Seroprevalence among Blood Donors, Japan, 2022
A nationwide survey of SARS-CoV-2 antinucleocapsid seroprevalence among blood donors in Japan revealed that, as of November 2022, infection-induced seroprevalence of the population was 28.6% (95% CI 27.6%–29.6%). Seroprevalence studies might complement routine surveillance and ongoing monitoring eff...
Autores principales: | Kinoshita, Ryo, Arashiro, Takeshi, Kitamura, Noriko, Arai, Satoru, Takahashi, Koki, Suzuki, Tadaki, Suzuki, Motoi, Yoneoka, Daisuke |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Centers for Disease Control and Prevention
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10461656/ https://www.ncbi.nlm.nih.gov/pubmed/37506681 http://dx.doi.org/10.3201/eid2909.230365 |
Ejemplares similares
-
National seroepidemiological study of COVID‐19 after the initial rollout of vaccines: Before and at the peak of the Omicron‐dominant period in Japan
por: Arashiro, Takeshi, et al.
Publicado: (2023) -
Duration of Infectious Virus Shedding by SARS-CoV-2 Omicron Variant–Infected Vaccinees
por: Takahashi, Kenichiro, et al.
Publicado: (2022) -
Nonnegligible Seroprevalence and Predictors of Murine Typhus, Japan
por: Aita, Tetsuro, et al.
Publicado: (2023) -
Impact of the Coming‐of‐Age Day and ceremony on the risk of SARS‐CoV‐2 transmission in Japan: A natural‐experimental study based on national surveillance data
por: Ko, Yura K., et al.
Publicado: (2022) -
Impact of airline network on the global importation risk of mpox, 2022
por: Kinoshita, Ryo, et al.
Publicado: (2023)